IDEAYA Biosciences, Inc. Balance Sheet
IDYA / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
IDEAYA Biosciences, Inc. had $1.1B in total assets and $1.0B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112.8M | $84.4M | $157.0M | $68.6M | $92.0M | $34.1M | $34.1M | $20.5M | $6.0M |
| Current Assets | $666.7M | $689.7M | $532.6M | $370.5M | $251.0M | $288.6M | $101.7M | $90.7M | - |
| PP&E (Net) | $8.2M | $9.0M | $6.2M | $6.5M | $4.8M | $4.3M | $4.6M | $5.2M | - |
| Total Assets | $1.1B | $1.1B | $649.3M | $388.0M | $381.3M | $298.3M | $113.0M | $96.5M | - |
| Current Liabilities | $58.8M | $46.1M | $27.1M | $31.7M | $45.2M | $38.6M | $6.9M | $5.4M | - |
| Shareholders' Equity | $1.0B | $1.1B | $621.1M | $349.5M | $301.5M | -$48.9M | $100.4M | -$48.9M | -$15.7M |